A股異動 | 隆基股份(601012.SH)漲超5%續創歷史新高 簽訂57億元重大采購合同
格隆匯8月3日丨隆基股份(601012.SH)高開高走,盤中高見59.89元再創歷史新高,現報59.69元,漲5.09%,暫成交15億元,最新總市值2251億元。隆基股份昨日公佈,全資子公司與吳江南玻、東莞南玻簽訂光伏玻璃採購協議,預估合同總金額約57億元,佔公司2019年營業成本的約24%。此外,隆基官網近日發佈最新單晶硅片價格,單晶硅片P型M6 175μm厚度(166/223mm)最新報價¥3.03。單晶硅片P型158.75/223mm 175μm厚度硅片最新報價¥2.90。與上次相比,M6上漲0.3元/片,G1上漲0.27元/片。值得注意的是,這是隆基時隔7天再次上調價格。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.